Vijay Pande leaves a16z to launch VZVC, a small, AI-driven biotech fund
Vijay Pande, who built Andreessen Horowitz's biotech investing practice into a nearly $4 billion operation, has departed to co-found a much smaller firm called VZVC with longtime investor Zach Werner. The new fund makes only a handful of concentrated investments each year instead of dozens, forgoes associates, and leans heavily on AI tools to run its operations.